Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune Checkpoint Inhibitor-induced Sicca Syndrome.
Bitoun S, Rousseau A, Gosset M, Belkhir R, Lazure T, Mariette X, Nocturne G. Bitoun S, et al. Among authors: nocturne g. Rheum Dis Clin North Am. 2024 May;50(2):291-300. doi: 10.1016/j.rdc.2024.02.004. Rheum Dis Clin North Am. 2024. PMID: 38670727 Review.
Identification of distinct subgroups of Sjögren's disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts.
Nguyen Y, Nocturne G, Henry J, Ng WF, Belkhir R, Desmoulins F, Bergé E, Morel J, Perdriger A, Dernis E, Devauchelle-Pensec V, Sène D, Dieudé P, Couderc M, Fauchais AL, Larroche C, Vittecoq O, Salliot C, Hachulla E, Le Guern V, Gottenberg JE, Mariette X, Seror R. Nguyen Y, et al. Among authors: nocturne g. Lancet Rheumatol. 2024 Apr;6(4):e216-e225. doi: 10.1016/S2665-9913(23)00340-5. Epub 2024 Mar 1. Lancet Rheumatol. 2024. PMID: 38437852 Free PMC article.
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis.
Astouati Q, Machet T, Houssais C, Noury JB, Allenbach Y, Gallay L, Quere B, Assan F, Benveniste O, Broner J, Duffau P, Espitia A, Grasland A, Hayem G, Guern VL, Martis N, Mariampillai K, Nocturne G, Mariette X, Meyer A, Mulleman D, Devauchelle-Pensec V, Collet A, Launay D, Hachulla E, Cornec D, Guellec D, Sanges S. Astouati Q, et al. Among authors: nocturne g. Rheumatology (Oxford). 2024 Mar 1:keae129. doi: 10.1093/rheumatology/keae129. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38430004
Characterisation of airway disease associated with Sjögren disease.
Meudec L, Debray MP, Beurnier A, Marques C, Juge PA, Dhote R, Larroche C, Fauchais AL, Dernis E, Vittecoq O, Saraux A, Gottenberg JE, Hachulla E, Le Guern V, Dieudé P, Seror R, Mariette X, Nocturne G. Meudec L, et al. Among authors: nocturne g. RMD Open. 2024 Feb 29;10(1):e003866. doi: 10.1136/rmdopen-2023-003866. RMD Open. 2024. PMID: 38428976 Free PMC article.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study.
de Frémont GM, Costedoat-Chalumeau N, Lazaro E, Belkhir R, Guettrot-Imbert G, Morel N, Nocturne G, Molto A, Goulenok T, Diot E, Perard L, Ferreira-Maldent N, Le Besnerais M, Limal N, Martis N, Abisror N, Debouverie O, Richez C, Sobanski V, Maurier F, Sauvetre G, Levesque H, Timsit MA, Tieulié N, Orquevaux P, Bienvenu B, Mahevas M, Papo T, Lartigau-Roussin C, Chauvet E, Berthoux E, Sarrot-Reynauld F, Raffray L, Couderc M, Silva NM, Jourde-Chiche N, Belhomme N, Thomas T, Poindron V, Queyrel-Moranne V, Delforge J, Le Ray C, Pannier E, Mariette X, Le Guern V, Seror R; GR2 Study Group. de Frémont GM, et al. Among authors: nocturne g. Lancet Rheumatol. 2023 Jun;5(6):e330-e340. doi: 10.1016/S2665-9913(23)00099-1. Epub 2023 May 8. Lancet Rheumatol. 2023. PMID: 38251600
[18F]FDG-PET/CT in Polymyalgia Rheumatica: An Update and Future Aspects.
Gheysens O, de Ponfilly MP, Nocturne G, Seror R, Besson FL, Jamar F. Gheysens O, et al. Among authors: nocturne g. Semin Nucl Med. 2024 May;54(3):371-378. doi: 10.1053/j.semnuclmed.2023.10.003. Epub 2023 Nov 28. Semin Nucl Med. 2024. PMID: 38030423 Review.
115 results